Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

Hypofractionated stereotactic body radiation therapy as monotherapy for intermediate-risk prostate cancer

<p>Abstract</p> <p>Background</p> <p>Hypofractionated stereotactic body radiation therapy (SBRT) has been advanced as monotherapy for low-risk prostate cancer. We examined the dose distributions and early clinical outcomes using this modality for the treatment of interm...

Full description

Bibliographic Details
Main Authors: Ju Andrew W, Wang Hongkun, Oermann Eric K, Sherer Benjamin A, Uhm Sunghae, Chen Viola J, Pendharkar Arjun V, Hanscom Heather N, Kim Joy S, Lei Siyuan, Suy Simeng, Lynch John H, Dritschilo Anatoly, Collins Sean P
Format: Article
Language:English
Published: BMC 2013-01-01
Series:Radiation Oncology
Subjects:
Stereotactic body radiotherapy
Prostate cancer
SBRT
CyberKnife
Intermediate-risk
Monotherapy
Hypofractionation
Online Access:http://www.ro-journal.com/content/8/1/30

Internet

http://www.ro-journal.com/content/8/1/30

Similar Items